How People in Eight European Countries Felt About the Safety, Effectiveness, and Necessity of COVID-19 Vaccination: A Cross-Sectional Survey.

How People in Eight European Countries Felt About the Safety, Effectiveness, and Necessity of COVID-19 Vaccination: A Cross-Sectional Survey.

Publication date: Feb 06, 2025

Background/objectives: Attitudes towards COVID-19 vaccination vary globally, influenced by political and cultural factors. This research aimed to assess the views of people without a healthcare qualification in Europe on COVID-19 vaccination safety, effectiveness, and necessity as well as how well informed they felt. The secondary outcomes focused on how respondents’ views were affected by demographic and context factors and included a comparison by country of the level of feeling well informed. Methods: A mixed-method cross-sectional online survey in eight European countries, using convenience sampling. Results: A total of 1008 adults completed the survey, 60% of whom were female. While only 44. 1% considered the vaccines safe, 43. 5% effective, and 44. 9% necessary, 80. 0% had been vaccinated. Four in ten adults strongly agreed that they were well informed, while over a quarter did not answer the question. Younger respondents, well-informed individuals, and German respondents were more inclined to perceive COVID-19 vaccination as both effective and necessary. Conclusions: Motivations for vaccination included perceived health and social benefits, while concerns included a preference for “natural immunity”, the rapid development of the vaccine, and potential unknown long-term effects. A correlation existed between respondents feeling well informed about the different COVID-19 vaccines in their country and the likelihood of having been vaccinated.

Open Access PDF

Concepts Keywords
Europe COVID-19
Female Europe
German population
Political public health
Vaccinated SARS-CoV-2
vaccination refusal
vaccine hesitancy
vaccine uptake

Semantics

Type Source Name
disease MESH COVID-19
disease IDO country
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Coenzyme M
disease MESH infection
disease IDO symptom
disease MESH death
disease MESH adverse drug reactions
disease IDO process
disease IDO quality
pathway REACTOME Translation

Original Article

(Visited 1 times, 1 visits today)